News

Preclinical supplies of the drug substance have been recently secured and the preclinical development process is being initiated. The company intends to test the benzoylphenylurea (BPU) agent utilizing

The tests showed that CEL-2000 is equivalent or possibly superior to Enbrel in slowing disease progression and lessening symptoms in mice. In addition, the vaccine has the potential

The new Intego positron emission tomography infusion system is claimed to be the first infusion system available in the US to automate the fluorodeoxyglucose (FDG) delivery process. According

Under the terms of the agreement, effective June 17, 2008, Roche will pay ThromboGenics and BioInvent an upfront payment of E50 million. In addition, ThromboGenics and BioInvent could

The preliminary clinical findings indicate that when used with PET technology, BMS747158 demonstrates a favorable radiation dosimetry profile and is generally well-tolerated. Exploratory analyses from this study showed

The Phase III study (study 105) was a randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of Acurox tablets for relief of moderate to severe pain

The Testosterone replacement in hypogonadal men with either metabolic syndrome or Type 2 diabetes study looked at the effects of Tostran on insulin resistance, diabetic control, lipids, quality

In this single blinded study seven Type 2 diabetic subjects were dosed with AKP-020 and two with placebo for 28 days. Over the 28-day period, both placebo subjects

Pharmacokinetic analysis revealed that 131I-TM601 rapidly clears from the blood stream and is then quickly removed from the body through the urinary system. Additionally, imaging localization analysis showed